Identification of plasma protein profiles associated with risk groups of prostate cancer patients.

Research output: Contribution to journalArticle

Abstract

Early detection of prostate cancer (PC) using prostate-specific antigen (PSA) in blood reduces PC-death among unscreened men. However, due to modest specificity of PSA at commonly used cut-offs, there are urgent needs for additional biomarkers contributing enhanced risk classification among men with modestly elevated PSA.

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cell and Molecular Biology
Original languageEnglish
Pages (from-to)951-962
JournalProteomics Clinical Applications
Volume8
Issue number11-12
Publication statusPublished - 2014
Publication categoryResearch
Peer-reviewedYes

Total downloads

No data available